Phase II Study of Panitumumab with Fluorouracil in Patients With KRAS Wild-type Metastatic Colorectal Cancer(PF Study)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 May 2016
At a glance
- Drugs Fluorouracil (Primary) ; Panitumumab (Primary) ; Capecitabine; Folinic acid; Gimeracil/oteracil/tegafur; Tegafur/uracil
- Indications Colorectal cancer
- Focus Therapeutic Use
- 02 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 09 Jun 2012 Additional lead investigator (Hideyuki Mishima) identified as reported by University Hospital Medical Information Network - Japan record.
- 04 Feb 2012 New trial record